Preview

Obesity and metabolism

Advanced search

Vitamin D the missing element in the treatment of obesity and diabetes?

https://doi.org/10.14341/omet13304

Abstract

Vitamin D supplementation has a significant positive effect on the skeletal system (prevention of rickets/osteomalacia; in severe deficiency, reduction in the risk of certain fractures and falls). However, for extraskeletal effects, which include acute respiratory infections, cardiovascular diseases, cancer, type 2 diabetes, and obesity, the data are mixed. Large randomized clinical trials in non-selected populations have generally failed to confirm a significant clinical benefit from vitamin D supplementation, while meta-analytic and subgroup data indicate a significant benefit in individuals with corrected baseline deficiency. Dosage regimen and baseline 25(OH)D status are key effect modifiers. Therefore, experts currently recommend a targeted approach screening and correcting deficiency and insufficiency in at-risk groups, achieving and maintaining target vitamin D levels. This literature review focuses on the effects of vitamin D supplementation in patients with obesity and carbohydrate metabolism disorders.

About the Authors

E. A. Pigarova
Endocrinology Research Centre
Russian Federation

Ekaterina A. Pigarova, MD, PhD

Scopus Author ID: 55655098500; Researcher ID: T-9424-2018

Moscow


Competing Interests:

Авторы декларируют отсутствие явных и потенциальных конфликтов интересов, связанных с содержанием настоящей статьи.



I. A. Katsobashvili
Endocrinology Research Centre
Russian Federation

Ilana A. Katsobashvili, MD

11 Dm. Ulyanova street, 117292 Moscow


Competing Interests:

Авторы декларируют отсутствие явных и потенциальных конфликтов интересов, связанных с содержанием настоящей статьи.



L. K. Dzeranova
Endocrinology Research Centre
Russian Federation

Larisa K. Dzeranova, MD, PhD

Moscow


Competing Interests:

Авторы декларируют отсутствие явных и потенциальных конфликтов интересов, связанных с содержанием настоящей статьи.



References

1. Dedov II, Mel’nichenko GA, Mokrysheva NG, Pigarova EA, Povaliaeva AA, Rozhinskaya LYa, Belaya ZhE, Dzeranova LK, Karonova TL, Suplotova LA, Troshina EА. Draft federal clinical practice guidelines for the diagnosis, treatment, and prevention of vitamin D deficiency. Osteoporosis and Bone Diseases. 2021;24(4):4-26. (In Russ.) doi: https://doi.org/10.14341/osteo12937

2. Schumacher LD, Jäger L, Meier R, Rachamin Y, Senn O, Rosemann T, Markun S. Trends and Between-Physician Variation in Laboratory Testing: A Retrospective Longitudinal Study in General Practice. J Clin Med. 2020;9(6):1787. doi: https://doi.org/10.3390/jcm9061787

3. Pigarova EA, Petrushkina AA. Non-classical effects of vitamin D. Osteoporosis and Bone Diseases. 2017;20(3):90-101. (In Russ.) doi: https://doi.org/10.14341/osteo2017390-101

4. Moon RJ, D’ Angelo S, Curtis EM, Ward KA, Crozier SR, et al.; MAVIDOS Trial Group. Pregnancy vitamin D supplementation and offspring bone mineral density in childhood follow-up of a randomized controlled trial. Am J Clin Nutr. 2024;120(5):1134-1142. doi: https://doi.org/10.1016/j.ajcnut.2024.09.014

5. Reid IR. Vitamin D Effect on Bone Mineral Density and Fractures. Endocrinol Metab Clin North Am. 2017;46(4):935-945. doi: https://doi.org/10.1016/j.ecl.2017.07.005

6. Chevalley T, Brandi ML, Cashman KD, Cavalier E, Harvey NC, Maggi S, et al. Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group. Aging Clin Exp Res. 2022;34(11):2603-2623. doi: https://doi.org/10.1007/s40520-022-02279-6

7. Tice JA, Halalau A, Burke H. Vitamin D Does Not Prevent Cancer or Cardiovascular Disease: The VITAL Trial: Manson JE, Cook NR, Lee IM, Christen W, Bassuk SS, Mora S, Gibson H, Gordon D, Copeland T, D’Agostino D, Friedenberg G, Ridge C, Bube V, Giovannucci EL, Willett WC, Buring JE (2019) Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease. N Engl J Med 380 (1):33-44. J Gen Intern Med. 2020. doi: https://doi.org/10.1007/s11606-020-05648-x

8. Manson JE, Bassuk SS, Lee IM, Cook NR, Albert MA, et al. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials. 2012;33(1):159-71. doi: https://doi.org/10.1016/j.cct.2011.09.009

9. Zhang Y, Fang F, Tang J, Jia L, Feng Y, Xu P, Faramand A. Association between vitamin D supplementation and mortality: systematic review and meta-analysis. BMJ. 2019;366:l4673. doi: https://doi.org/10.1136/bmj.l4673. Erratum in: BMJ. 2020;370:m2329. doi: https://doi.org/10.1136/bmj.m2329

10. Herrmann M, Farrell CL, Pusceddu I, FabregatCabello N, Cavalier E. Assessment of vitamin D status - a changing landscape. Clin Chem Lab Med. 2017;55(1):3-26. doi: https://doi.org/10.1515/cclm-2016-0264

11. Maganeva IS, Pigarova EA, Shulpekova NV, Dzeranova LK, Eremkina AK, et al. [Vitamin D metabolite and calcium phosphorus metabolism in in patients with primary hyperparathyroidism on the background of bolus therapy with colecalciferol]. Probl Endokrinol (Mosk). 2021;67(6):68-79. Russian. doi: https://doi.org/10.14341/probl12851

12. Alonso N, Zelzer S, Eibinger G, Herrmann M. Vitamin D Metabolites: Analytical Challenges and Clinical Relevance. Calcif Tissue Int. 2023;112(2):158-177. doi: https://doi.org/10.1007/s00223-022-00961-5

13. Povaliaeva AA, Pigarova EA, Romanova AA, Dzeranova LK, Zhukov AY, Rozhinskaya LY. Vitamin D-binding protein: multifunctional component of blood serum. Annals of the Russian academy of medical sciences. 2021;76(1):103-110. (In Russ.) doi: https://doi.org/10.15690/vramn1396

14. Zheng S, Zhu L, Wang Y, Hua Y, Ying J, Chen J. Key genes of vitamin D metabolism and their roles in the risk and prognosis of cancer. Front Genet. 2025;16:1598525. doi: https://doi.org/10.3389/fgene.2025.1598525

15. Dhawan P, Peng X, Sutton AL, MacDonald PN, Croniger CM, et al. Functional cooperation between CCAAT/enhancer-binding proteins and the vitamin D receptor in regulation of 25-hydroxyvitamin D3 24-hydroxylase. Mol Cell Biol. 2005;25(1):472-87. doi: https://doi.org/10.1128/MCB.25.1.472-487.2005

16. Shri Preethi M, Premkumar K, Asha Devi S. Molecular docking study on vitamin D supplements to understand their interaction with VDR-RXRα heterodimer and VDRE of TAGAP gene. J Biomol Struct Dyn. 2023;41(15):7009-7018. doi: https://doi.org/10.1080/07391102.2022.2114939

17. Doms S, Verlinden L, Janssens I, Vanhevel J, Eerlings R, et al. Coactivator-independent vitamin D receptor signaling causes severe rickets in mice, that is not prevented by a diet high in calcium, phosphate, and lactose. Bone Res. 2024;12(1):44. doi: https://doi.org/10.1038/s41413-024-00343-7

18. Zhang Y, Zhou J, Hua L, Li P, Wu J, Shang S, Deng F, Luo J, et al. Vitamin D receptor (VDR) on the cell membrane of mouse macrophages participates in the formation of lipopolysaccharide tolerance: mVDR is related to the effect of artesunate to reverse LPS tolerance. Cell Commun Signal. 2023;21(1):124. doi: https://doi.org/10.1186/s12964-023-01137-w

19. Pigarova EA, Dzeranova LK. Obesity, diabetes and vitamin D. Obesity and metabolism. 2024;21(3):316-324. (In Russ.) doi: https://doi.org/10.14341/omet13161

20. Wood RJ. Vitamin D and adipogenesis: new molecular insights. Nutr Rev. 2008;66(1):40-6. doi: https://doi.org/10.1111/j.1753-4887.2007.00004.x

21. Ding C, Gao D, Wilding J, Trayhurn P, Bing C. Vitamin D signalling in adipose tissue. British Journal of Nutrition. 2012;108(11):1915-1923. doi: https://doi.org/10.1017/S0007114512003285

22. Szymczak-Pajor I, Miazek K, Selmi A, Balcerczyk A, Śliwińska A. The Action of Vitamin D in Adipose Tissue: Is There the Link between Vitamin D Deficiency and Adipose TissueRelated Metabolic Disorders? Int J Mol Sci. 2022;23(2):956. doi: https://doi.org/10.3390/ijms23020956

23. Nimitphong H, Guo W, Holick MF, Fried SK, Lee MJ. Vitamin D Inhibits Adipokine Production and Inflammatory Signaling Through the Vitamin D Receptor in Human Adipocytes. Obesity (Silver Spring). 2021;29(3):562-568. doi: https://doi.org/10.1002/oby.23109

24. Greco EA, Lenzi A, Migliaccio S. Role of Hypovitaminosis D in the Pathogenesis of Obesity-Induced Insulin Resistance. Nutrients. 2019;11(7):1506. doi: https://doi.org/10.3390/nu11071506

25. Wu J, Atkins A, Downes M, Wei Z. Vitamin D in Diabetes: Uncovering the Sunshine Hormone’s Role in Glucose Metabolism and Beyond. Nutrients. 2023;15(8):1997. doi: https://doi.org/10.3390/nu15081997

26. Mitri J, Pittas AG. Vitamin D and diabetes. Endocrinol Metab Clin North Am. 2014;43(1):205-32. doi: https://doi.org/10.1016/j.ecl.2013.09.010

27. Taneera J, Yaseen D, Youssef M, Khalique A, Al Shehadat OS, Mohammed AK, Bustanji Y, Madkour MI, El-Huneidi W. Vitamin D augments insulin secretion via calcium influx and upregulation of voltage calcium channels: Findings from INS-1 cells and human islets.. 2025;599:112472. doi: https://doi.org/10.1016/j.mce.2025.112472

28. Pigarova EA, Dzeranova LК, Yatsenko DA. Absorption and metabolism of vitamin D in health and in gastrointestinal tract diseases. Obesity and metabolism. 2022;19(1):123-133. (In Russ.) doi: https://doi.org/10.14341/omet12835

29. Povalyaeva A.A., Pigarova E.A., Romanova A.A., Dzeranova L.K., Zhukov A.Yu., Rozhinskaya L.Ya. Vitamin D-binding protein as a multifunctional component of blood serum. // Bulletin of the Russian Academy of Medical Sciences. - 2021. - T. 76. - No. 1. — P.103-110. (In Russ.)

30. Cipriani C, Pepe J, Piemonte S, Colangelo L, Cilli M, Minisola S. Vitamin d and its relationship with obesity and muscle. Int J Endocrinol. 2014;2014:841248. doi: https://doi.org/10.1155/2014/841248

31. Christensen EI, Birn H. Megalin and cubilin: multifunctional endocytic receptors. Nat Rev Mol Cell Biol. 2002;3(4):256-66. doi: https://doi.org/10.1038/nrm778

32. Bikle DD, Schwartz J. Vitamin D Binding Protein, Total and Free Vitamin D Levels in Different Physiological and Pathophysiological Conditions. Front Endocrinol (Lausanne). 2019;10:317. doi: https://doi.org/10.3389/fendo.2019.00317

33. Bouillon R, Schuit F, Antonio L, Rastinejad F. Vitamin D Binding Protein: A Historic Overview. Front Endocrinol (Lausanne). 2020;10:910. doi: https://doi.org/10.3389/fendo.2019.00910

34. Suplotova LA, Avdeeva VA, Pigarova EA, Rozhinskaya LYa. The «cut-off point» of vitamin D: a method of suppressing excessive secretion of PTH. Obesity and metabolism. 2019;16(3):88-93. (In Russ.) doi: https://doi.org/10.14341/omet10196

35. Pigarova EA, Rozhinskaya LYa, Belaya JE, Dzeranova LK, Karonova TL, Ilyin AV, Melnichenko GA, Dedov II. Russian Association of Endocrinologists recommendations for diagnosis, treatment and prevention of vitamin D deficiency in adults. Problems of Endocrinology. 2016;62(4):60-84. (In Russ.) doi: https://doi.org/10.14341/probl201662460-84

36. Żmijewski MA. Nongenomic Activities of Vitamin D. Nutrients. 2022;14(23):5104. doi: https://doi.org/10.3390/nu14235104

37. Park CY, Han SN. The Role of Vitamin D in Adipose Tissue Biology: Adipocyte Differentiation, Energy Metabolism, and Inflammation. J Lipid Atheroscler. 2021;10(2):130-144. doi: https://doi.org/10.12997/jla.2021.10.2.130

38. Li X, Liu Y, Wang J, Chen X, Reichetzeder C, et al. Vitamin D Is Associated with Lipid Metabolism: A Sex- and Age-Dependent Analysis of a Large Outpatient Cohort. Nutrients. 2024;16(22):3936. doi: https://doi.org/10.3390/nu16223936

39. Yu M, Chen S, Liu X, Dong H, Wang DC. The impact of vitamin D supplementation on glycemic control and lipid metabolism in polycystic ovary syndrome: a systematic review of randomized controlled trials. BMC Endocr Disord. 2025;25(1):110. doi: https://doi.org/10.1186/s12902-025-01920-5.

40. Guo Y, Zhu L, Ge Y, Zhang H. Improving effect of vitamin D supplementation on obesity-related diabetes in rats. Minerva Endocrinol. 2020;45(1):29-35. doi: https://doi.org/10.23736/S0391-1977.18.02914-0.

41. Nimitphong H, Guo W, Holick MF, Fried SK, Lee MJ. Vitamin D Inhibits Adipokine Production and Inflammatory Signaling Through the Vitamin D Receptor in Human Adipocytes. Obesity (Silver Spring). 2021;29(3):562-568. doi: https://doi.org/10.1002/oby.23109

42. Nikooyeh B, Neyestani TR. Can vitamin D be considered an adiponectin secretagogue? A systematic review and meta-analysis. J Steroid Biochem Mol Biol. 2021;212:105925. doi: https://doi.org/10.1016/j.jsbmb.2021.105925.

43. Wei X, Wang Y, Liu W, Zhang D, Zhou C, Jiang Z, Li W, Li X, Miao Y. Vitamin D against diabetic adipose tissue inflammation through SHP-1/STAT3 pathway. Int Immunopharmacol. 2025;162:115131. doi: https://doi.org/10.1016/j.intimp.2025.115131

44. Sun X, Zemel MB. 1Alpha,25-dihydroxyvitamin D3 modulation of adipocyte reactive oxygen species production. Obesity (Silver Spring). 2007;15(8):1944-53. doi: https://doi.org/10.1038/oby.2007.232

45. Musazadeh V, Zarezadeh M, Ghalichi F, Kalajahi FH, Ghoreishi Z. Vitamin D supplementation positively affects anthropometric indices: Evidence obtained from an umbrella meta-analysis. Front Nutr. 2022;9:980749. doi: https://doi.org/10.3389/fnut.2022.980749

46. Perna S. Is Vitamin D Supplementation Useful for Weight Loss Programs? A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina (Kaunas). 2019;55(7):368. doi: https://doi.org/10.3390/medicina55070368

47. Corsello A, Macchi M, D’Oria V, Pigazzi C, Alberti I, Treglia G, De Cosmi V, Mazzocchi A, Agostoni C, Milani GP. Effects of vitamin D supplementation in obese and overweight children and adolescents: A systematic review and meta-analysis. Pharmacol Res. 2023;192:106793. doi: https://doi.org/10.1016/j.phrs.2023.106793

48. Golzarand M, Hollis BW, Mirmiran P, Wagner CL, Shab-Bidar S. Vitamin D supplementation and body fat mass: a systematic review and meta-analysis. Eur J Clin Nutr. 2018;72(10):1345-1357. doi: https://doi.org/10.1038/s41430-018-0132-z

49. Hu L, Velu P, Prabahar K, Hernández-Wolters B, Kord-Varkaneh H, Xu Y. Effect of Vitamin D Supplementation on Lipid Profile in Overweight or Obese Women: A Meta-analysis and Systematic Review of Randomized Controlled Trials. Nutr Rev. 2025;83(9):1657-1668. doi: https://doi.org/10.1093/nutrit/nuae226

50. Nikooyeh B, Neyestani TR. Can vitamin D be considered an adiponectin secretagogue? A systematic review and meta-analysis. J Steroid Biochem Mol Biol. 2021;212:105925. doi: https://doi.org/10.1016/j.jsbmb.2021.105925

51. He LP, Li CP, Liu CW, Gu W. The Regulatory Effect of Vitamin D on Pancreatic Beta Cell Secretion in Patients with Type 2 Diabetes. Curr Med Chem. 2024. doi: https://doi.org/10.2174/0109298673270429240805050928

52. Bornstedt ME, Gjerlaugsen N, Pepaj M, Bredahl MKL, Thorsby PM. Vitamin D Increases Glucose Stimulated Insulin Secretion from Insulin Producing Beta Cells (INS1E). Int J Endocrinol Metab. 2019;17(1):e74255. doi: https://doi.org/10.5812/ijem.74255

53. Yu J, Sharma P, Girgis CM, Gunton JE. Vitamin D and Beta Cells in Type 1 Diabetes: A Systematic Review. Int J Mol Sci. 2022;23(22):14434. doi: https://doi.org/10.3390/ijms232214434

54. Molani-Gol R, Rafraf M, Safari S. Effects of vitamin D supplementation on metabolic parameters, anthropometric measures, and diabetes risk in patients with prediabetes: an umbrella review of metaanalyses of randomized controlled trials. Nutr Metab (Lond). 2025;22(1):99. doi: https://doi.org/10.1186/s12986-025-00994-1

55. Chen W, Liu L, Hu F. Efficacy of vitamin D supplementation on glycaemic control in type 2 diabetes: An updated systematic review and meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2024;26(12):5713-5726. doi: https://doi.org/10.1111/dom.15941

56. Zhang XJ, Wang HF, Gao X, Zhao Y. Effects of Oral Vitamin D Supplementation on Vitamin D Levels and Glycemic Parameters in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis. Biomed Environ Sci. 2025;38(6):716-726. doi: https://doi.org/10.3967/bes2025.066

57. Chien, MC., Huang, CY., Wang, JH. et al. Effects of vitamin D in pregnancy on maternal and offspring health-related outcomes: An umbrella review of systematic review and meta-analyses. Nutr. Diabetes. 2024; 14(1):35. doi: https://doi.org/10.1038/s41387-024-00296-0

58. Karonova TL, Salukhov VV, Dzgoeva FKh, Pigarova EA, Galstyan GR, Bulgakova SV, Vagapova GR, Volkova NI, Kiseleva TP, Markova TN, Remizov OV, Skakun LA, Tul`ganova VL, Yavlyanskaya VV. Vitamin D deficiency in overweight patients: current strategies and practical aspects. Problems of Endocrinology. 2025;71(1):92-98. (In Russ.) doi: https://doi.org/10.14341/probl13557

59. Official instructions for the drug Soligamma®(In Russ.)


Supplementary files

1. Рисунок 1. Костные и внекостные (плейотропные) эффекты витамина D.
Subject
Type Исследовательские инструменты
View (1MB)    
Indexing metadata ▾

Review

For citations:


Pigarova E.A., Katsobashvili I.A., Dzeranova L.K. Vitamin D the missing element in the treatment of obesity and diabetes? Obesity and metabolism. 2026;23(2):85-95. (In Russ.) https://doi.org/10.14341/omet13304

Views: 181

JATS XML

ISSN 2071-8713 (Print)
ISSN 2306-5524 (Online)